# Rayyan vs ValueSense

Rayyan records 1,116,437 monthly visits with +7.9% month-over-month growth and Freemium pricing. ValueSense records 8,984 monthly visits with -25.4% growth and Freemium pricing.

| Metric | [Rayyan](https://openaitools.app/tool/rayyan) | [ValueSense](https://openaitools.app/tool/valuesense) |
| :--- | :--- | :--- |
| Website URL | https://www.rayyan.ai | https://valuesense.io |
| Categories | AI Research Tool, AI Productivity Tools, AI Project Management, AI Workflow | AI Investing, AI For Finance, AI Stock Trading, AI Research Tool |
| Pricing Model | Freemium | Freemium |
| Monthly Visits | 1,116,437 | 8,984 |
| MoM Growth Rate | +7.9% | -25.4% |
| Primary Market | United States | United States |
| Direct Visits | 677,880 | 3,654 |
| Review Score | 4.5 | 4.2 |
| Saved Count | 1 | 0 |
| Supported Platforms | Website | Website |

## Rayyan

Rayyan is a dedicated platform for systematic literature reviews and evidence synthesis, used by more than a million researchers at tens of thousands of institutions across over 190 countries. Rather than being a general reference manager, it maps directly onto the standard review pipeline: importing references from multiple sources, organizing them into a library, inviting collaborators with defined roles, deduplicating the corpus, and then working through title and abstract screening followed by full-text screening with conflict resolution.

The AI layer centers on ResearchPilot, which provides zero-shot relevance ratings, an AI Analyzer, an AI Reviewer, and automated data extraction designed to be dramatically faster than manual workflows. Rayyan also ships a Systematic Auto-Resolver that can deduplicate up to 200,000 references based on your own protocol in a single action, plus a mobile app that lets reviewers screen studies on the go or even offline. Small productivity touches like programmable hot keys and randomized data sampling help teams divide large workloads without losing coordination.

Beyond screening, Rayyan covers the back half of a review too. Teams define structured data extraction fields, apply PICO frameworks to structure evaluation, capture study-level data, assess Risk of Bias with dedicated tooling, and generate PRISMA flow diagrams for publication. A strong emphasis on auditability and transparency means every decision is traceable and reproducible. An API is available to extend Rayyan beyond the interface, and pricing runs from a generous free tier for basic use up to enterprise plans for institutional research programs.

**Pricing & Plans:** Free forever for basic use with no credit card required, making core screening and deduplication accessible to individual researchers. Paid and enterprise plans unlock advanced capabilities such as ResearchPilot, Risk of Bias, and institutional features; pricing details are available on the site and through sales.

- **Automatic deduplication:** The Systematic Auto-Resolver deduplicates up to 200,000 references using your own inclusion and exclusion protocol with one click.
- **ResearchPilot AI:** ResearchPilot delivers zero-shot relevance ratings, an AI Analyzer, an AI Reviewer, and auto-extraction to speed up search, screening, and data capture.
- **Screening and conflict resolution:** Work through title, abstract, and full-text screening with inclusion and exclusion tagging, conflict resolution, and blinded reviewer modes.
- **Data extraction and PRISMA reporting:** Capture structured study data with configurable extraction fields, apply PICO frameworks, and export results with auto-generated PRISMA diagrams.
- **Collaboration and scalability:** Randomly sample subsets, divide workloads, manage roles, and screen offline via the mobile app, with full audit trails for reproducibility.

**Strengths:** Covers the full systematic review workflow from import to PRISMA export; ResearchPilot AI speeds up search, screening, and extraction; Deduplicates up to 200,000 references from your own protocol; Offline-capable mobile app for screening anywhere

**Limitations:** Full-text screening workflows still demand significant reviewer time; Some advanced AI capabilities are aimed at enterprise and institutional plans; Requires structuring your review protocol to get the most from automation

[Profile (Markdown)](https://openaitools.app/tool/rayyan.md)

## ValueSense

ValueSense is a stock analysis platform built for value-oriented investors who want hedge-fund-style analytics without a hedge-fund budget. It pulls valuation models, screeners, quality metrics and market signals into a single workspace, so you can move from idea generation to deeper research without juggling ten different tabs. The core premise is intrinsic value: rather than chasing price momentum, ValueSense helps you estimate what a business is worth and compare that estimate against the market.

The toolkit centers on intrinsic-value calculators — reverse DCF, DCF, Peter Lynch fair value and earnings power value — alongside a stock screener with AI filters and backtesting, quality ratings, AI earnings analysis, a stock heatmap, an insiders tracker and super-investor profiles. A stock ideas section surfaces 360+ automated ideas across categories such as moat stocks, quality growers and undervalued small caps, giving you a running start on research.

ValueSense also includes a portfolio tracker and earnings calendar so you can monitor holdings and catalysts in the same place. Plans run from a free starting tier up to Explorer, Pro and Enterprise levels, with the more advanced tools and premium ideas unlocked at higher tiers. The company stresses that ValueSense is a data and analytics provider, not a broker or adviser, so any investment decision remains your own.

**Pricing & Plans:** ValueSense uses a tiered model: a free starting tier plus paid Explorer and Pro plans, with an Enterprise option. Higher tiers unlock more intrinsic value tools, screening, stock ideas and data. See the pricing page for current details.

- **Intrinsic value toolkit:** Work with reverse DCF, DCF, Peter Lynch fair value and earnings power value to estimate what a stock is really worth before buying.
- **AI stock screener with backtesting:** Filter the market with AI-driven presets and custom filters, and backtest screens to see how they would have performed.
- **Curated stock ideas:** Browse 360+ automated stock ideas across categories like moat stocks, quality grower and undervalued names, refreshed regularly.
- **Insiders and super investors:** Track super-investor portfolios and insider buying and selling to see where informed money is moving.
- **Portfolio and market dashboards:** Monitor holdings with a portfolio tracker, earnings calendar, stock heatmap, charts and quality ratings in one place.

**Strengths:** Combines valuation tools, screeners and signals in one workspace; Strong focus on intrinsic value rather than price momentum; AI-powered screener with backtesting and presets; Insider and super-investor tracking for idea generation

**Limitations:** Geared toward fundamentally-minded investors, less suited to pure day-trading or technical-only strategies; The richest tools and premium stock ideas sit behind higher-tier plans; It is a data and analytics service, not a broker, so you cannot execute trades inside it; Reliable intrinsic value estimates still require you to interpret assumptions and inputs

[Profile (Markdown)](https://openaitools.app/tool/valuesense.md)

## Frequently Asked Questions

### How do Rayyan and ValueSense compare in monthly traffic?

Rayyan has 1,116,437 monthly visits, while ValueSense has 8,984. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Rayyan has a month-over-month growth rate of +7.9%; ValueSense has -25.4%.

### How does pricing compare?

Rayyan: Freemium. Free forever for basic use with no credit card required, making core screening and deduplication accessible to individual researchers. Paid and enterprise plans unlock advanced capabilities such as ResearchPilot, Risk of Bias, and institutional features; pricing details are available on the site and through sales. ValueSense: Freemium. ValueSense uses a tiered model: a free starting tier plus paid Explorer and Pro plans, with an Enterprise option. Higher tiers unlock more intrinsic value tools, screening, stock ideas and data. See the pricing page for current details.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Provides a completely free and open academic search database, but lacks collaborative literature review screening tools. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | Great for finding scientific agreement and evidence-backed answers, but lacks dedicated screening queues and systematic review extraction forms. | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Excellent for reading, chatting with, and summarizing individual papers, but less structured for multi-reviewer systematic review screening. | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Stronger automated data extraction and evidence synthesis from papers, but less focused on collaborative title and abstract screening workflows. | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Offers powerful citation analysis and smart citation metrics, but is less tailored for full PRISMA systematic review workflows. | [.md](https://openaitools.app/tool/scite.md) |
| 6 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features. | [.md](https://openaitools.app/tool/researchrabbit.md) |
| 7 | [Connected Papers](https://openaitools.app/tool/connected-papers) | 750,576 | +3.1% | Freemium | Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction. | [.md](https://openaitools.app/tool/connected-papers.md) |
| 8 | [Paperguide](https://openaitools.app/tool/paperguide) | 371,972 | -2.9% | Freemium | Provides solid literature search and reference management tools, but lacks Rayyan's specialized collaborative screening interface. | [.md](https://openaitools.app/tool/paperguide.md) |
| 9 | [Aime](https://openaitools.app/tool/aime) | 260,428 | +11.4% | Freemium | AI investing copilot for stock research, screening and market signals | [.md](https://openaitools.app/tool/aime.md) |
| 10 | [Danelfin](https://openaitools.app/tool/danelfin-com) | 216,830 | -11.1% | Freemium | AI-driven stock scores that rank every pickable stock by probability of beating the market | [.md](https://openaitools.app/tool/danelfin-com.md) |

---
Source: https://openaitools.app/compare/rayyan-vs-valuesense

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)